Latest News
Web Date: April 2, 2012

FDA Denies Bisphenol A Petition

Regulation: Agency finds insufficient data to ban controversial chemical in food packaging
Department: Government & Policy
News Channels: Environmental SCENE, Biological SCENE
Keywords: bisphenol A, food safety, FDA, endocrine disrupter

The Food & Drug Administration has rejected a petition from the Natural Resources Defense Council (NRDC) to ban bisphenol A (BPA) in food packaging. The advocacy group filed the petition in October 2008, claiming that exposure to BPA can cause endocrine-disrupting health effects in humans, especially infants and children.

FDA was not persuaded by the evidence provided in NRDC’s petition. “The best course of action at this time is to continue our review and study of emerging data on BPA,” David H. Dorsey, acting associate commissioner for policy and planning at FDA, wrote in a March 30 denial letter to NRDC. “FDA is performing, monitoring, and reviewing new studies and data as they become available, and depending on the results, any of these studies or data could influence FDA’s assessment and future regulatory decisions about BPA,” he stated.

BPA has been under intense scrutiny for many years because it mimics estrogen and has been linked to cancer and obesity in humans. Although government agencies around the world have declared BPA safe in food packaging, consumer pressure has persuaded manufacturers to seek alternatives.

“Over the last three years, the industry has been working very hard to look for alternative technologies to BPA-based can coatings,” says John M. Rost, chairman of the North American Metal Packaging Alliance, an industry group. The effort has been driven by customer requests for alternatives, not scientific safety concerns, he stresses.

So far, such alternatives have been successful only for limited applications. For the majority of packaged foods, the alternatives don’t have the performance characteristics of BPA-based epoxy resins, Rost says.

It would be difficult to implement a ban on BPA in food packaging today because “FDA hasn’t authorized a broad-based alternative material, one that can address the range of food applications that are currently handled by BPA epoxies,” says Mitchell Cheeseman, managing director in environmental and health sciences at the law firm Steptoe & Johnson and former acting director of FDA’s Office of Food Additive Safety.

FDA’s rejection of the petition won’t be its final word on BPA. Last month, Rep. Edward J. Markey (D-Mass.) filed three different petitions urging FDA to ban BPA in food packaging (C&EN, March 26, page 36). The American Chemistry Council, an industry trade group, has also petitioned FDA to ban BPA in baby bottles and sippy cups because manufacturers are no longer using BPA in those products.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society
Comments
Jesse_EngAmer (Tue Apr 03 00:06:53 EDT 2012)
To quote Gina Solomon at the Huffington Post: "FDA to Consumers: We're Still Thinking About It; Sorry You're Still Eating It"http://huff.to/HRm4ne

This is a ridiculous avoidance of regulation. The FDA needs to buckle down and do the job they tax American consumers for. Protecting American consumers.
CindyNMN (Wed Apr 11 09:45:19 EDT 2012)
I would advise Jesse_EngAmer to read what the FDA actually said. All of it.

The FDA is not and should not be in the business of conducting witch trials, no matter what somebody at Huffington Post says.

The FDA should not forbid anything on the basis of irreproducible results or irrelevant studies. We're still waiting for the avowed enemies of BPA to get around to doing relevant, reproducible studies under GLP conditions. Instead they spend all their energy talking to nonscientific journalists, trying to scare consumers. Why the avoidance? Do they have an inkling what the results of GLP studies might be?

Leave A Comment

*Required to comment